Skip to main content
Oncoimmunology logoLink to Oncoimmunology
. 2017 Apr 7;6(4):e1311485. doi: 10.1080/2162402X.2017.1311485

Erratum

PMCID: PMC5414869  PMID: 28507814

Article Title: CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer

Authors(s): Shu Su, Zhengyun Zou, Fangjun Chen, Naiqing Ding, Juan Du, Jie Shao, Lin Li, Yao Fu, Bian Hu, Yang Yang, Huizi Sha, Fanyan Meng, Jia Wei, Xingxu Huang, and Baorui Liu

Journal: OncoImmunology

Bibliometrics: Published in Volume 6, Number 1, e1249558

DOI: 10.1080/2162402X.2016.1249558

Publisher: Taylor & Francis

In the article listed above Shu Su was incorrectly listed as the corresponding author of the article. Baorui Liu and Xingxu Huang should have been listed as the article's corresponding authors. The correct contact information for the corresponding authors is listed below. The publisher apologizes for the error.

CONTACT. Baorui Liu baoruiliu@nju.edu.cn; Xingxu Huang huangxx@shanghaitech.edu.cn


Articles from Oncoimmunology are provided here courtesy of Taylor & Francis

RESOURCES